Haem augments and iron chelation decreases toll‐like receptor 4 mediated inflammation in monocytes from sickle cell patients

normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. British Journal of Haematology, 178, 816. Durie, B.G. , Harousseau, J.L. , Miguel, J.S. , Blad e, J., Barlogie, B. , Anderson, K. , Gertz, M. , Dimopoulos, M. , Westin, J., Sonneveld, P., Ludwig, H. , Gahrton, G. , Beksac, M. , Crowley, J., Belch, A. , Boccadaro, M. , Cavo, M. , Turesson, I. , Joshua, D. , Vesole, D. , Kyle, R. , Alexanian, R. , Tricot, G. , Attal, M. , Merlini, G. , Powles, R. , Richardson, P., Shimizu, K. , Tosi, P., Morgan, G. & Rajkumar, S.V. ; for the International Myeloma Working Group. (2006) International uniform response criteria for multiple myeloma. Leukemia, 20, 1467–1473. Kumar, S. , Paiva, B. , Anderson, K.C. , Durie, B. , Landgren, O. , Moreau, P., Munshi, N. , Lonial, S. , Blad e, J., Mateos, M.V. , Dimopoulos, M. , Kastritis, E. , Boccadoro, M. , Orlowski, R. , Goldschmidt, H. , Spencer, A. , Hou, J., Chng, W.J., Usmani, S.Z. , Zamagni, E. , Shimizu, K. , Jagannath, S. , Johnsen, H.E. , Terpos, E. , Reiman, A. , Kyle, R.A. , Sonneveld, P., Richardson, P.G. , McCarthy, P., Ludwig, H. , Chen, W. , Cavo, M. , Harousseau, J.L. , Lentzsch, S. , Hillengass, J., Palumbo, A. , Orfao, A. , Rajkumar, S.V. , San Miguel, J. & Avet-Loiseau, H. (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. The Lancet Oncology, 17, e328–e346. Ludwig, H. , Milosavljevic, D. , Zojer, N. , Zojer, N. , Faint, J.M. , Bradwell, A.R. , H€ ubl, W. & Harding, S.J. (2013) Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients. Leukemia, 27, 213–219. Mart ınez-L opez, J., Paiva, B. , L opez-Anglada, L. , Mateos, M.V. , Cedena, T. , Vidr ıales, M.B. , S aezG omez, M.A., Contreras, T. , Oriol, A. , Rapado, I. , Teruel, A.I., Cord on, L. , Blanchard, M.J., Bengoechea, E. , Palomera, L. , de Arriba, F. , Cueto-Felgueroso, C. , Orfao, A. , Blad e, J., San Miguel, J.F. & Lahuerta, J.J.; Spanish Multiple Myeloma Group/Program for the Study of Malignant Blood Diseases Therapeutics (GEM/ PETHEMA) Cooperative Study Group. (2015) Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality. Blood, 126, 858–862. Paolini, L. , Di Noto, G. , Maffina, F. , Martellosio, G. , Radeghieri, A. , Luigi, C. & Ricotta, D. (2015) Comparison of Hevylite IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia. Annals of Clinical Biochemistry, 52, 337–345. Suehara, Y. , Takamatsu, H. , Fukumoto, K. , Fujisawa, M. , Narita, K. , Usui, Y. , Takeuchi, M. , Endean, K. & Matsue, K. (2017) Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma. Cancer Science, 108, 187–192. Tacchetti, P., Pezzi, A. , Zamagni, E. , Pantani, L. , Rocchi, S. , Zannetti, B.A., Mancuso, K. , Rizzello, I. & Cavo, M. (2017) Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents. Haematologica, 102, e104–e107.